congress
presentations

Psych Congress Elevate

Las Vegas, NV
May 30-June 4, 2024

PDF screenshot

AXS-05 | Major Depressive Disorder

AXS-05 (Auvelity®) in Major Depressive Disorder: Pooled Data from Two Six-Week Controlled Trials (GEMINI and ASCEND)

view/download

PDF screenshot

AXS-05 | Major Depressive Disorder

Real-World Auvelity® (AXS-05) Patient Characteristics in Major Depressive Disorder

AXS-05 | Major Depressive Disorder

Dr. Andrew Muzyk, PharmD describes the "Real-World Auvelity® (AXS-05) Patient Characteristics in Major Depressive Disorder" Psych Congress Elevate 2024 poster

view

PDF screenshot

AXS-05 | Major Depressive Disorder

Real-World Treatment Experiences and Expectations by Symptom Severity in Patients With Major Depressive Disorder

view/download

PDF screenshot

AXS-05 | Major Depressive Disorder

Evaluation of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder Using the Interest-Activity Domain

view/download

AXS-05 | Major Depressive Disorder

Dr. Roger McIntyre, MD, FRCPC describes the "Evaluation of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder Using the Interest-Activity Domain" Psych Congress Elevate 2024 poster

view

This site is intended for registered attendees of the respective Congress.
This site contains scientific presentations on investigational products and/or investigational uses of approved products for Axsome or its partners sponsored studies.
The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.
Marketing authorization, approval status, and prescribing information for approved products varies by country. Please seek further details from the health authority in your country such as approved product labeling.

AXSOME and its logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.

© 2023 Axsome Therapeutics, Inc. All rights reserved. One World Trade Center, 22nd Floor, New York, NY 10007 info@axsome.com